Skip to main content
MyPeptideMatch logoMyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated February 2026

L-Carnitine Injection Dosing Protocol: 200 mg Vial — Fat Oxidation & Energy Guide

L-Carnitine injection protocol for the 200 mg vial — intramuscular or subcutaneous dosing for fatty acid transport, exercise performance, and metabolic support.

Go to peptide profileCalculate your dose

Quickstart highlights

L-Carnitine (beta-hydroxy-beta-methylaminobutyric acid) is an amino acid derivative synthesized from lysine and methionine, essential for long-chain fatty acid transport across the inner mitochondrial membrane via the carnitine acyltransferase system.

  • Concentration: 200 mg/mL (200 mg vial typically supplied as solution).
  • At 200 mg/mL: 200 mg = 1 mL (standard IM dose) three times weekly.
  • Injected L-Carnitine achieves 3–5x higher plasma levels than equivalent oral doses due to gut bacterial TMAO conversion.
  • Inject 30–60 minutes before aerobic exercise for maximum fatty acid transport enhancement.
  • L-Carnitine is FDA-approved (Carnitor) for primary carnitine deficiency and valproic acid toxicity.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-12——3x weekly (Mon/Wed/Fri) IM or SC200 mg (1 mL) per injection; clinical dose used in fatigue and renal disease studies; one vial = one injection
alt——3x weekly IM500 mg (2.5 mL at 200 mg/mL) — exercise performance dose used in Brass EP et al. athletic studies; draw from multiple vials

Reconstitution steps

  1. L-Carnitine injection vials are typically supplied as ready-to-inject solution — no reconstitution required.
  2. If lyophilized powder: draw 1 mL sterile water; inject down the vial wall and swirl gently.
  3. Final concentration: 200 mg/mL. At 200 mg/mL: 200 mg = 1 mL.
  4. Label with date; refrigerate at 2–8 °C. Use within 28 days.

Supplies needed

12-week plan

  • 36 vials
  • 36 syringes
  • 0 mL bac water
  • 36 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Enhance mitochondrial fatty acid transport, improve exercise-induced fat oxidation, and support carnitine-deficient states through regular intramuscular or subcutaneous L-Carnitine injections.

Cycle length: 12 weeks on.

Off-cycle: L-Carnitine can be used continuously — no required off-cycle. Assess energy levels and athletic performance quarterly.

Storage & handling

Ready-to-inject L-carnitine: refrigerate at 2–8 °C; use by expiry date. Lyophilized: store below 25 °C; reconstituted: use within 28 days.

Injection & tracking tips

  • Intramuscular injection (outer thigh or ventrogluteal) is preferred for L-Carnitine due to the 200 mg/mL concentration — 1 mL IM is standard and well-tolerated.
  • Inject 30–60 minutes before aerobic exercise or immediately post-workout for fat oxidation support.
  • Some practitioners use L-Carnitine IV push (slow IV over 2–3 minutes) for immediate pre-exercise delivery — requires IV access and medical supervision.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Track exercise duration to fatigue and perceived exertion weekly.
  • Measure fasting triglyceride levels at baseline and 12 weeks.
  • Record TMAO (trimethylamine-N-oxide) levels at baseline and 12 weeks if cardiovascular risk is a concern.
Log your cycle in the calculator →

How this works & references

L-Carnitine (beta-hydroxy-beta-methylaminobutyric acid) is an amino acid derivative synthesized from lysine and methionine, essential for long-chain fatty acid transport across the inner mitochondrial membrane via the carnitine acyltransferase system. Injectable L-Carnitine achieves approximately 3–5x higher plasma carnitine levels than equivalent oral doses (which have 14–18% bioavailability due to gut bacterial TMAO conversion). Carnitine deficiency causes exercise intolerance and muscle weakness in dialysis patients, cancer patients, and patients on valproic acid. Brass et al. (2000, JPEN) demonstrated carnitine supplementation improved exercise tolerance in hemodialysis patients. Rebouche (2004) reviewed oral vs. injectable pharmacokinetics demonstrating injectable superiority.

Sources

Frequently asked questions

Does injectable L-Carnitine burn more fat than oral L-Carnitine supplements?
Injectable L-Carnitine achieves significantly higher plasma and tissue carnitine levels than oral supplements due to the poor oral bioavailability (14–18%) caused by gut bacterial degradation to TMAO. For individuals with normal renal function and adequate dietary carnitine intake, supplementation benefit is modest. For carnitine-deficient states (dialysis, vegan diet, genetic deficiency), injection provides clear benefit.
What is TMAO and should I be concerned about it from L-Carnitine?
TMAO (trimethylamine-N-oxide) is a hepatic metabolite of trimethylamine, produced when gut bacteria convert L-Carnitine to TMA. Elevated TMAO is associated with increased cardiovascular risk in observational studies. Injectable L-Carnitine bypasses gut bacterial conversion, reducing TMAO production versus oral L-Carnitine. Individuals with high baseline TMAO or cardiovascular history may prefer injectable administration.
Is L-Carnitine injection FDA-approved?
Yes — Carnitor (levocarnitine) injection is FDA-approved for primary carnitine deficiency, secondary carnitine deficiency due to inborn errors of metabolism, and acute and chronic treatment of carnitine deficiency in hemodialysis patients. Off-label injectable use for athletic performance and weight loss is not FDA-approved.
Can L-Carnitine be combined with GLP-1 agonists?
Yes — L-Carnitine supports fatty acid oxidation in the mitochondrial compartment, complementing GLP-1-mediated appetite reduction. When patients on semaglutide or tirzepatide are losing significant weight, ensuring adequate carnitine levels supports efficient fat oxidation and lean mass preservation during the weight loss phase.
How does injection site choice (IM vs. SC) affect L-Carnitine absorption?
IM injection (outer thigh, ventrogluteal) provides faster absorption peak (30–60 minutes to peak plasma) due to higher muscle blood flow. SC injection has slower, sustained release (60–90 minutes to peak). At 200 mg/mL, SC injection of 1 mL is well-tolerated. IM is preferred in clinical practice for pre-exercise timing; SC is acceptable for convenience.

Related protocols

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

View protocol

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

View protocol

Testagen Dosing Protocol: 20 mg Vial — Testicular Bioregulator & Testosterone Support Guide

Testagen (Lys-Glu-Asp-Gly tetrapeptide) Russian testicular bioregulator dosing guide — Leydig cell gene normalization for testosterone production optimization and male reproductive aging support.

View protocol

Prostamax Dosing Protocol: 20 mg Vial — Prostate Bioregulator Guide

Prostamax (Lys-Asp-Glu-Leu tetrapeptide) Russian prostate bioregulator dosing guide — prostatic epithelial gene normalization for BPH, prostate aging, and urinary symptom support.

View protocol

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Browse vetted clinicsView full peptide profile →